Medi Assist Q2 & H1FY27: Revenue up 13.8% to ₹492.4 Cr, PAT surges 60.2%
Medi Assist Healthcare Services Limited reported H1FY27 total income of ₹492.4 Cr (+13.8% YoY) and PAT of ₹49.2 Cr (+60.2% YoY). Q2FY27 saw total income at ₹245.4 Cr (+4.5% YoY) and PAT at ₹21.6 Cr (+167.5% YoY). The company announced a share buyback of up to ₹49.3 Cr at ₹425 per share.
The significant financial growth in key metrics like revenue and profit, coupled with the announcement of a share buyback, are material events that are likely to have a substantial positive impact on investor sentiment and the company's valuation.
The company reported strong year-on-year growth in total income, EBITDA, and PAT for both Q2 and H1FY27, along with an improved EBITDA margin. The announcement of a share buyback also indicates financial strength and confidence in future performance.
Medi Assist Healthcare Services Limited has released its investor presentation for Q2 and H1FY27, showcasing significant financial growth. For the first half of FY27, the company reported a total income of ₹492.4 crore, marking a 13.8% year-on-year increase. EBITDA stood at ₹97.2 crore, up 19.0% YoY, and reported Profit After Tax (PAT) surged by 60.2% to ₹49.2 crore. Operating revenue for H1FY27 was ₹478.0 crore, a 13.0% rise YoY, with an EBITDA margin of 20.3% and a PAT margin of 10.0%.
In Q2FY27, total income reached ₹245.4 crore, a 4.5% increase YoY. EBITDA for the quarter was ₹49.2 crore, up 23.9% YoY, and reported PAT saw a substantial rise of 167.5% to ₹21.6 crore. Operating revenue for Q2FY27 was ₹241.5 crore, up 3.9% YoY, with an improved EBITDA margin of 20.4% (up 331 bps YoY) and a PAT margin of 8.8% (up 536 bps YoY).
The company highlighted strong performance across its business models. The India TPA segment saw revenue growth of 11.9% in H1FY27 to ₹437.5 crore, with premiums managed reaching ₹15,104 crore. The Platform & HBA segment exhibited robust growth with revenue up 69.8% to ₹19.8 crore, and premiums on the platform at ₹9,648 crore. The International segment (Mayfair) reported revenue of ₹20.7 crore in H1FY27, with an annualized book of business increasing by 17% and an addition of 14 corporate clients. Group revenue grew by 13.7% to ₹334.7 crore in H1FY27, with premiums managed at ₹13,939 crore and market share at 34.1%.
Management commentary emphasized the successful integration of Paramount, leading to margin recovery and a favorable shift towards higher-value platform and international revenue. The company is focusing on margin expansion and portfolio diversification in H2FY27. Medi Assist also announced a board-approved share buyback of up to ₹49.3 crore at ₹425 per share, funded from internal accruals, reflecting confidence in its long-term earnings trajectory and disciplined capital allocation.
What to do with a filing like this
Medi Assist Healthcare Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medi Assist Healthcare Services Limited. Read the original for the full detail.